शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSECCME GLOBAL LIMITED· Pharmaceuticals & BiotechnologyHighNeutral
Announced Fri, 6 Nov, 2026 · 11:35 IST

Promoter Varalakshmi buys 2.25 crore shares via preferential allotment

Promoter bought stakeOwnership Changes View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+4.1%Reaction day
₹37.39
prior close
₹36.01
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is usedpendingvs market: pending
Biotechnology peers, median of 5sector-0.9%+5.0% vs sector

On the reaction day the stock moved 5.0 pts more than its Biotechnology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
+0.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+4.1pendingpending-0.9+5.0
Next day
—————
2d
—————
3d
—————
4d
—————
5d
—————
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Biotechnology peers, median of 5Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Promoter Varalakshmi Venkataraman acquired 2,25,00,000 shares through a preferential allotment. Her holding rose from 55,72,300 shares (12.31%) to 2,80,72,300 shares (14.32%), an effective gain of 2.01 percentage points. The issue expanded paid-up capital from Rs 45.25 crore to Rs 196.09 crore. No shares were pledged or encumbered.

Likely market impact

The promoter's control increased, but the large issue diluted other shareholders and may reduce earnings per share if profits do not rise proportionately.